RFC
LJPC

Russell Frank Company’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Russell Frank Company’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23,536
Closed -$647K – 3181
2015
Q4 		$647K Buy
23,536
+9,224
+64% +$252K ﹤0.01% 2401
2015
Q3 		$398K Buy
+14,312
New +$451K ﹤0.01% 2541
2014
Q2 		– Sell
-38,497
Closed -$416K – 2987
2014
Q1 		$416K Buy
+38,497
New +$378K ﹤0.01% 2428

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Frank Company's LJPC Position: Q1 2016 in Review

Russell Frank Company sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2016, closing a stake of 23,536 shares — an estimated $647K sold.

Russell Frank Company first reported a position in LJPC in Q1 2014 and held it in 3 quarters. The position peaked at $647K in Q4 2015. 70 funds tracked by Wall St. Rank hold LJPC as of Q1 2016.

  • Russell Frank Company reported no remaining La Jolla Pharmaceutical Company position as of Q1 2016 after selling out during the quarter.
  • Russell Frank Company sold 23,536 La Jolla Pharmaceutical Company shares in Q1 2016, an estimated $647K.
  • Russell Frank Company first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 3 quarters.
  • Russell Frank Company's La Jolla Pharmaceutical Company position peaked at $647K in Q4 2015.
  • 70 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.